The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global COVID-19 Nasal Swab Test Market Research Report 2025
Synopsis
The global COVID-19 Nasal Swab Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for COVID-19 Nasal Swab Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for COVID-19 Nasal Swab Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of COVID-19 Nasal Swab Test include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc., Siemens Healthineers AG and QIAGEN N.V., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Nasal Swab Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Nasal Swab Test.
Report Scope
The COVID-19 Nasal Swab Test market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Nasal Swab Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Nasal Swab Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Roche Holding AG
Becton Dickinson & Company
3M Corporation
BioMerieux SA
Lucira Health
Mesa Biotech, Inc.
Siemens Healthineers AG
QIAGEN N.V.
Cepheid
LumiraDx Ltd.
Fluidigm Corporation
Quidel Corporation
GenMark Diagnostics, Inc.
Sherlock Biosciences
PrivaPath Diagnostics Limited
OraSure Technologies, Inc.
Segment by Type
Foam Tipped Swabs
Non-Woven
Others
Segment by Application
Hospital & Clinic
Laboratories & Diagnostics Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of COVID-19 Nasal Swab Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of COVID-19 Nasal Swab Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global COVID-19 Nasal Swab Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for COVID-19 Nasal Swab Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for COVID-19 Nasal Swab Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of COVID-19 Nasal Swab Test include Abbott Laboratories, Roche Holding AG, Becton Dickinson & Company, 3M Corporation, BioMerieux SA, Lucira Health, Mesa Biotech, Inc., Siemens Healthineers AG and QIAGEN N.V., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Nasal Swab Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Nasal Swab Test.
Report Scope
The COVID-19 Nasal Swab Test market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Nasal Swab Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Nasal Swab Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Roche Holding AG
Becton Dickinson & Company
3M Corporation
BioMerieux SA
Lucira Health
Mesa Biotech, Inc.
Siemens Healthineers AG
QIAGEN N.V.
Cepheid
LumiraDx Ltd.
Fluidigm Corporation
Quidel Corporation
GenMark Diagnostics, Inc.
Sherlock Biosciences
PrivaPath Diagnostics Limited
OraSure Technologies, Inc.
Segment by Type
Foam Tipped Swabs
Non-Woven
Others
Segment by Application
Hospital & Clinic
Laboratories & Diagnostics Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of COVID-19 Nasal Swab Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of COVID-19 Nasal Swab Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 COVID-19 Nasal Swab Test Market Overview
1.1 Product Overview and Scope of COVID-19 Nasal Swab Test
1.2 COVID-19 Nasal Swab Test Segment by Type
1.2.1 Global COVID-19 Nasal Swab Test Market Value Comparison by Type (2024-2030)
1.2.2 Foam Tipped Swabs
1.2.3 Non-Woven
1.2.4 Others
1.3 COVID-19 Nasal Swab Test Segment by Application
1.3.1 Global COVID-19 Nasal Swab Test Market Value by Application: (2024-2030)
1.3.2 Hospital & Clinic
1.3.3 Laboratories & Diagnostics Centers
1.4 Global COVID-19 Nasal Swab Test Market Size Estimates and Forecasts
1.4.1 Global COVID-19 Nasal Swab Test Revenue 2019-2030
1.4.2 Global COVID-19 Nasal Swab Test Sales 2019-2030
1.4.3 Global COVID-19 Nasal Swab Test Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 COVID-19 Nasal Swab Test Market Competition by Manufacturers
2.1 Global COVID-19 Nasal Swab Test Sales Market Share by Manufacturers (2019-2024)
2.2 Global COVID-19 Nasal Swab Test Revenue Market Share by Manufacturers (2019-2024)
2.3 Global COVID-19 Nasal Swab Test Average Price by Manufacturers (2019-2024)
2.4 Global COVID-19 Nasal Swab Test Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COVID-19 Nasal Swab Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COVID-19 Nasal Swab Test, Product Type & Application
2.7 COVID-19 Nasal Swab Test Market Competitive Situation and Trends
2.7.1 COVID-19 Nasal Swab Test Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest COVID-19 Nasal Swab Test Players Market Share by Revenue
2.7.3 Global COVID-19 Nasal Swab Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 COVID-19 Nasal Swab Test Retrospective Market Scenario by Region
3.1 Global COVID-19 Nasal Swab Test Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global COVID-19 Nasal Swab Test Global COVID-19 Nasal Swab Test Sales by Region: 2019-2030
3.2.1 Global COVID-19 Nasal Swab Test Sales by Region: 2019-2024
3.2.2 Global COVID-19 Nasal Swab Test Sales by Region: 2025-2030
3.3 Global COVID-19 Nasal Swab Test Global COVID-19 Nasal Swab Test Revenue by Region: 2019-2030
3.3.1 Global COVID-19 Nasal Swab Test Revenue by Region: 2019-2024
3.3.2 Global COVID-19 Nasal Swab Test Revenue by Region: 2025-2030
3.4 North America COVID-19 Nasal Swab Test Market Facts & Figures by Country
3.4.1 North America COVID-19 Nasal Swab Test Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America COVID-19 Nasal Swab Test Sales by Country (2019-2030)
3.4.3 North America COVID-19 Nasal Swab Test Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe COVID-19 Nasal Swab Test Market Facts & Figures by Country
3.5.1 Europe COVID-19 Nasal Swab Test Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe COVID-19 Nasal Swab Test Sales by Country (2019-2030)
3.5.3 Europe COVID-19 Nasal Swab Test Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COVID-19 Nasal Swab Test Market Facts & Figures by Country
3.6.1 Asia Pacific COVID-19 Nasal Swab Test Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific COVID-19 Nasal Swab Test Sales by Country (2019-2030)
3.6.3 Asia Pacific COVID-19 Nasal Swab Test Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America COVID-19 Nasal Swab Test Market Facts & Figures by Country
3.7.1 Latin America COVID-19 Nasal Swab Test Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America COVID-19 Nasal Swab Test Sales by Country (2019-2030)
3.7.3 Latin America COVID-19 Nasal Swab Test Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COVID-19 Nasal Swab Test Market Facts & Figures by Country
3.8.1 Middle East and Africa COVID-19 Nasal Swab Test Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa COVID-19 Nasal Swab Test Sales by Country (2019-2030)
3.8.3 Middle East and Africa COVID-19 Nasal Swab Test Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COVID-19 Nasal Swab Test Sales by Type (2019-2030)
4.1.1 Global COVID-19 Nasal Swab Test Sales by Type (2019-2024)
4.1.2 Global COVID-19 Nasal Swab Test Sales by Type (2025-2030)
4.1.3 Global COVID-19 Nasal Swab Test Sales Market Share by Type (2019-2030)
4.2 Global COVID-19 Nasal Swab Test Revenue by Type (2019-2030)
4.2.1 Global COVID-19 Nasal Swab Test Revenue by Type (2019-2024)
4.2.2 Global COVID-19 Nasal Swab Test Revenue by Type (2025-2030)
4.2.3 Global COVID-19 Nasal Swab Test Revenue Market Share by Type (2019-2030)
4.3 Global COVID-19 Nasal Swab Test Price by Type (2019-2030)
5 Segment by Application
5.1 Global COVID-19 Nasal Swab Test Sales by Application (2019-2030)
5.1.1 Global COVID-19 Nasal Swab Test Sales by Application (2019-2024)
5.1.2 Global COVID-19 Nasal Swab Test Sales by Application (2025-2030)
5.1.3 Global COVID-19 Nasal Swab Test Sales Market Share by Application (2019-2030)
5.2 Global COVID-19 Nasal Swab Test Revenue by Application (2019-2030)
5.2.1 Global COVID-19 Nasal Swab Test Revenue by Application (2019-2024)
5.2.2 Global COVID-19 Nasal Swab Test Revenue by Application (2025-2030)
5.2.3 Global COVID-19 Nasal Swab Test Revenue Market Share by Application (2019-2030)
5.3 Global COVID-19 Nasal Swab Test Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories COVID-19 Nasal Swab Test Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Roche Holding AG
6.2.1 Roche Holding AG Corporation Information
6.2.2 Roche Holding AG Description and Business Overview
6.2.3 Roche Holding AG COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Holding AG COVID-19 Nasal Swab Test Product Portfolio
6.2.5 Roche Holding AG Recent Developments/Updates
6.3 Becton Dickinson & Company
6.3.1 Becton Dickinson & Company Corporation Information
6.3.2 Becton Dickinson & Company Description and Business Overview
6.3.3 Becton Dickinson & Company COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Becton Dickinson & Company COVID-19 Nasal Swab Test Product Portfolio
6.3.5 Becton Dickinson & Company Recent Developments/Updates
6.4 3M Corporation
6.4.1 3M Corporation Corporation Information
6.4.2 3M Corporation Description and Business Overview
6.4.3 3M Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.4.4 3M Corporation COVID-19 Nasal Swab Test Product Portfolio
6.4.5 3M Corporation Recent Developments/Updates
6.5 BioMerieux SA
6.5.1 BioMerieux SA Corporation Information
6.5.2 BioMerieux SA Description and Business Overview
6.5.3 BioMerieux SA COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioMerieux SA COVID-19 Nasal Swab Test Product Portfolio
6.5.5 BioMerieux SA Recent Developments/Updates
6.6 Lucira Health
6.6.1 Lucira Health Corporation Information
6.6.2 Lucira Health Description and Business Overview
6.6.3 Lucira Health COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lucira Health COVID-19 Nasal Swab Test Product Portfolio
6.6.5 Lucira Health Recent Developments/Updates
6.7 Mesa Biotech, Inc.
6.6.1 Mesa Biotech, Inc. Corporation Information
6.6.2 Mesa Biotech, Inc. Description and Business Overview
6.6.3 Mesa Biotech, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mesa Biotech, Inc. COVID-19 Nasal Swab Test Product Portfolio
6.7.5 Mesa Biotech, Inc. Recent Developments/Updates
6.8 Siemens Healthineers AG
6.8.1 Siemens Healthineers AG Corporation Information
6.8.2 Siemens Healthineers AG Description and Business Overview
6.8.3 Siemens Healthineers AG COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Siemens Healthineers AG COVID-19 Nasal Swab Test Product Portfolio
6.8.5 Siemens Healthineers AG Recent Developments/Updates
6.9 QIAGEN N.V.
6.9.1 QIAGEN N.V. Corporation Information
6.9.2 QIAGEN N.V. Description and Business Overview
6.9.3 QIAGEN N.V. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.9.4 QIAGEN N.V. COVID-19 Nasal Swab Test Product Portfolio
6.9.5 QIAGEN N.V. Recent Developments/Updates
6.10 Cepheid
6.10.1 Cepheid Corporation Information
6.10.2 Cepheid Description and Business Overview
6.10.3 Cepheid COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cepheid COVID-19 Nasal Swab Test Product Portfolio
6.10.5 Cepheid Recent Developments/Updates
6.11 LumiraDx Ltd.
6.11.1 LumiraDx Ltd. Corporation Information
6.11.2 LumiraDx Ltd. COVID-19 Nasal Swab Test Description and Business Overview
6.11.3 LumiraDx Ltd. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LumiraDx Ltd. COVID-19 Nasal Swab Test Product Portfolio
6.11.5 LumiraDx Ltd. Recent Developments/Updates
6.12 Fluidigm Corporation
6.12.1 Fluidigm Corporation Corporation Information
6.12.2 Fluidigm Corporation COVID-19 Nasal Swab Test Description and Business Overview
6.12.3 Fluidigm Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fluidigm Corporation COVID-19 Nasal Swab Test Product Portfolio
6.12.5 Fluidigm Corporation Recent Developments/Updates
6.13 Quidel Corporation
6.13.1 Quidel Corporation Corporation Information
6.13.2 Quidel Corporation COVID-19 Nasal Swab Test Description and Business Overview
6.13.3 Quidel Corporation COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Quidel Corporation COVID-19 Nasal Swab Test Product Portfolio
6.13.5 Quidel Corporation Recent Developments/Updates
6.14 GenMark Diagnostics, Inc.
6.14.1 GenMark Diagnostics, Inc. Corporation Information
6.14.2 GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Description and Business Overview
6.14.3 GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.14.4 GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Product Portfolio
6.14.5 GenMark Diagnostics, Inc. Recent Developments/Updates
6.15 Sherlock Biosciences
6.15.1 Sherlock Biosciences Corporation Information
6.15.2 Sherlock Biosciences COVID-19 Nasal Swab Test Description and Business Overview
6.15.3 Sherlock Biosciences COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sherlock Biosciences COVID-19 Nasal Swab Test Product Portfolio
6.15.5 Sherlock Biosciences Recent Developments/Updates
6.16 PrivaPath Diagnostics Limited
6.16.1 PrivaPath Diagnostics Limited Corporation Information
6.16.2 PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Description and Business Overview
6.16.3 PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.16.4 PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Product Portfolio
6.16.5 PrivaPath Diagnostics Limited Recent Developments/Updates
6.17 OraSure Technologies, Inc.
6.17.1 OraSure Technologies, Inc. Corporation Information
6.17.2 OraSure Technologies, Inc. COVID-19 Nasal Swab Test Description and Business Overview
6.17.3 OraSure Technologies, Inc. COVID-19 Nasal Swab Test Sales, Revenue and Gross Margin (2019-2024)
6.17.4 OraSure Technologies, Inc. COVID-19 Nasal Swab Test Product Portfolio
6.17.5 OraSure Technologies, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COVID-19 Nasal Swab Test Industry Chain Analysis
7.2 COVID-19 Nasal Swab Test Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COVID-19 Nasal Swab Test Production Mode & Process
7.4 COVID-19 Nasal Swab Test Sales and Marketing
7.4.1 COVID-19 Nasal Swab Test Sales Channels
7.4.2 COVID-19 Nasal Swab Test Distributors
7.5 COVID-19 Nasal Swab Test Customers
8 COVID-19 Nasal Swab Test Market Dynamics
8.1 COVID-19 Nasal Swab Test Industry Trends
8.2 COVID-19 Nasal Swab Test Market Drivers
8.3 COVID-19 Nasal Swab Test Market Challenges
8.4 COVID-19 Nasal Swab Test Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global COVID-19 Nasal Swab Test Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global COVID-19 Nasal Swab Test Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global COVID-19 Nasal Swab Test Market Competitive Situation by Manufacturers in 2023
Table 4. Global COVID-19 Nasal Swab Test Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global COVID-19 Nasal Swab Test Sales Market Share by Manufacturers (2019-2024)
Table 6. Global COVID-19 Nasal Swab Test Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global COVID-19 Nasal Swab Test Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market COVID-19 Nasal Swab Test Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of COVID-19 Nasal Swab Test, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of COVID-19 Nasal Swab Test, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of COVID-19 Nasal Swab Test, Product Type & Application
Table 12. Global Key Manufacturers of COVID-19 Nasal Swab Test, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global COVID-19 Nasal Swab Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Nasal Swab Test as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global COVID-19 Nasal Swab Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global COVID-19 Nasal Swab Test Sales by Region (2019-2024) & (Units)
Table 18. Global COVID-19 Nasal Swab Test Sales Market Share by Region (2019-2024)
Table 19. Global COVID-19 Nasal Swab Test Sales by Region (2025-2030) & (Units)
Table 20. Global COVID-19 Nasal Swab Test Sales Market Share by Region (2025-2030)
Table 21. Global COVID-19 Nasal Swab Test Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global COVID-19 Nasal Swab Test Revenue Market Share by Region (2019-2024)
Table 23. Global COVID-19 Nasal Swab Test Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global COVID-19 Nasal Swab Test Revenue Market Share by Region (2025-2030)
Table 25. North America COVID-19 Nasal Swab Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America COVID-19 Nasal Swab Test Sales by Country (2019-2024) & (Units)
Table 27. North America COVID-19 Nasal Swab Test Sales by Country (2025-2030) & (Units)
Table 28. North America COVID-19 Nasal Swab Test Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America COVID-19 Nasal Swab Test Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe COVID-19 Nasal Swab Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe COVID-19 Nasal Swab Test Sales by Country (2019-2024) & (Units)
Table 32. Europe COVID-19 Nasal Swab Test Sales by Country (2025-2030) & (Units)
Table 33. Europe COVID-19 Nasal Swab Test Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe COVID-19 Nasal Swab Test Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific COVID-19 Nasal Swab Test Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific COVID-19 Nasal Swab Test Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific COVID-19 Nasal Swab Test Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific COVID-19 Nasal Swab Test Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific COVID-19 Nasal Swab Test Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America COVID-19 Nasal Swab Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America COVID-19 Nasal Swab Test Sales by Country (2019-2024) & (Units)
Table 42. Latin America COVID-19 Nasal Swab Test Sales by Country (2025-2030) & (Units)
Table 43. Latin America COVID-19 Nasal Swab Test Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America COVID-19 Nasal Swab Test Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa COVID-19 Nasal Swab Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa COVID-19 Nasal Swab Test Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa COVID-19 Nasal Swab Test Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa COVID-19 Nasal Swab Test Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa COVID-19 Nasal Swab Test Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global COVID-19 Nasal Swab Test Sales (Units) by Type (2019-2024)
Table 51. Global COVID-19 Nasal Swab Test Sales (Units) by Type (2025-2030)
Table 52. Global COVID-19 Nasal Swab Test Sales Market Share by Type (2019-2024)
Table 53. Global COVID-19 Nasal Swab Test Sales Market Share by Type (2025-2030)
Table 54. Global COVID-19 Nasal Swab Test Revenue (US$ Million) by Type (2019-2024)
Table 55. Global COVID-19 Nasal Swab Test Revenue (US$ Million) by Type (2025-2030)
Table 56. Global COVID-19 Nasal Swab Test Revenue Market Share by Type (2019-2024)
Table 57. Global COVID-19 Nasal Swab Test Revenue Market Share by Type (2025-2030)
Table 58. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Type (2019-2024)
Table 59. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Type (2025-2030)
Table 60. Global COVID-19 Nasal Swab Test Sales (Units) by Application (2019-2024)
Table 61. Global COVID-19 Nasal Swab Test Sales (Units) by Application (2025-2030)
Table 62. Global COVID-19 Nasal Swab Test Sales Market Share by Application (2019-2024)
Table 63. Global COVID-19 Nasal Swab Test Sales Market Share by Application (2025-2030)
Table 64. Global COVID-19 Nasal Swab Test Revenue (US$ Million) by Application (2019-2024)
Table 65. Global COVID-19 Nasal Swab Test Revenue (US$ Million) by Application (2025-2030)
Table 66. Global COVID-19 Nasal Swab Test Revenue Market Share by Application (2019-2024)
Table 67. Global COVID-19 Nasal Swab Test Revenue Market Share by Application (2025-2030)
Table 68. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Application (2019-2024)
Table 69. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Laboratories Corporation Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Laboratories COVID-19 Nasal Swab Test Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. Roche Holding AG Corporation Information
Table 76. Roche Holding AG Description and Business Overview
Table 77. Roche Holding AG COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Roche Holding AG COVID-19 Nasal Swab Test Product
Table 79. Roche Holding AG Recent Developments/Updates
Table 80. Becton Dickinson & Company Corporation Information
Table 81. Becton Dickinson & Company Description and Business Overview
Table 82. Becton Dickinson & Company COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Becton Dickinson & Company COVID-19 Nasal Swab Test Product
Table 84. Becton Dickinson & Company Recent Developments/Updates
Table 85. 3M Corporation Corporation Information
Table 86. 3M Corporation Description and Business Overview
Table 87. 3M Corporation COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. 3M Corporation COVID-19 Nasal Swab Test Product
Table 89. 3M Corporation Recent Developments/Updates
Table 90. BioMerieux SA Corporation Information
Table 91. BioMerieux SA Description and Business Overview
Table 92. BioMerieux SA COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BioMerieux SA COVID-19 Nasal Swab Test Product
Table 94. BioMerieux SA Recent Developments/Updates
Table 95. Lucira Health Corporation Information
Table 96. Lucira Health Description and Business Overview
Table 97. Lucira Health COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lucira Health COVID-19 Nasal Swab Test Product
Table 99. Lucira Health Recent Developments/Updates
Table 100. Mesa Biotech, Inc. Corporation Information
Table 101. Mesa Biotech, Inc. Description and Business Overview
Table 102. Mesa Biotech, Inc. COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Mesa Biotech, Inc. COVID-19 Nasal Swab Test Product
Table 104. Mesa Biotech, Inc. Recent Developments/Updates
Table 105. Siemens Healthineers AG Corporation Information
Table 106. Siemens Healthineers AG Description and Business Overview
Table 107. Siemens Healthineers AG COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Siemens Healthineers AG COVID-19 Nasal Swab Test Product
Table 109. Siemens Healthineers AG Recent Developments/Updates
Table 110. QIAGEN N.V. Corporation Information
Table 111. QIAGEN N.V. Description and Business Overview
Table 112. QIAGEN N.V. COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. QIAGEN N.V. COVID-19 Nasal Swab Test Product
Table 114. QIAGEN N.V. Recent Developments/Updates
Table 115. Cepheid Corporation Information
Table 116. Cepheid Description and Business Overview
Table 117. Cepheid COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Cepheid COVID-19 Nasal Swab Test Product
Table 119. Cepheid Recent Developments/Updates
Table 120. LumiraDx Ltd. Corporation Information
Table 121. LumiraDx Ltd. Description and Business Overview
Table 122. LumiraDx Ltd. COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. LumiraDx Ltd. COVID-19 Nasal Swab Test Product
Table 124. LumiraDx Ltd. Recent Developments/Updates
Table 125. Fluidigm Corporation Corporation Information
Table 126. Fluidigm Corporation Description and Business Overview
Table 127. Fluidigm Corporation COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Fluidigm Corporation COVID-19 Nasal Swab Test Product
Table 129. Fluidigm Corporation Recent Developments/Updates
Table 130. Quidel Corporation Corporation Information
Table 131. Quidel Corporation Description and Business Overview
Table 132. Quidel Corporation COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Quidel Corporation COVID-19 Nasal Swab Test Product
Table 134. Quidel Corporation Recent Developments/Updates
Table 135. GenMark Diagnostics, Inc. Corporation Information
Table 136. GenMark Diagnostics, Inc. Description and Business Overview
Table 137. GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. GenMark Diagnostics, Inc. COVID-19 Nasal Swab Test Product
Table 139. GenMark Diagnostics, Inc. Recent Developments/Updates
Table 140. Sherlock Biosciences Corporation Information
Table 141. Sherlock Biosciences Description and Business Overview
Table 142. Sherlock Biosciences COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sherlock Biosciences COVID-19 Nasal Swab Test Product
Table 144. Sherlock Biosciences Recent Developments/Updates
Table 145. PrivaPath Diagnostics Limited Corporation Information
Table 146. PrivaPath Diagnostics Limited Description and Business Overview
Table 147. PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. PrivaPath Diagnostics Limited COVID-19 Nasal Swab Test Product
Table 149. PrivaPath Diagnostics Limited Recent Developments/Updates
Table 150. OraSure Technologies, Inc. Corporation Information
Table 151. OraSure Technologies, Inc. Description and Business Overview
Table 152. OraSure Technologies, Inc. COVID-19 Nasal Swab Test Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. OraSure Technologies, Inc. COVID-19 Nasal Swab Test Product
Table 154. OraSure Technologies, Inc. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. COVID-19 Nasal Swab Test Distributors List
Table 158. COVID-19 Nasal Swab Test Customers List
Table 159. COVID-19 Nasal Swab Test Market Trends
Table 160. COVID-19 Nasal Swab Test Market Drivers
Table 161. COVID-19 Nasal Swab Test Market Challenges
Table 162. COVID-19 Nasal Swab Test Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of COVID-19 Nasal Swab Test
Figure 2. Global COVID-19 Nasal Swab Test Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global COVID-19 Nasal Swab Test Market Share by Type in 2023 & 2030
Figure 4. Foam Tipped Swabs Product Picture
Figure 5. Non-Woven Product Picture
Figure 6. Others Product Picture
Figure 7. Global COVID-19 Nasal Swab Test Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global COVID-19 Nasal Swab Test Market Share by Application in 2023 & 2030
Figure 9. Hospital & Clinic
Figure 10. Laboratories & Diagnostics Centers
Figure 11. Global COVID-19 Nasal Swab Test Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global COVID-19 Nasal Swab Test Market Size (2019-2030) & (US$ Million)
Figure 13. Global COVID-19 Nasal Swab Test Sales (2019-2030) & (Units)
Figure 14. Global COVID-19 Nasal Swab Test Average Price (US$/Unit) & (2019-2030)
Figure 15. COVID-19 Nasal Swab Test Report Years Considered
Figure 16. COVID-19 Nasal Swab Test Sales Share by Manufacturers in 2023
Figure 17. Global COVID-19 Nasal Swab Test Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest COVID-19 Nasal Swab Test Players: Market Share by Revenue in 2023
Figure 19. COVID-19 Nasal Swab Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global COVID-19 Nasal Swab Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America COVID-19 Nasal Swab Test Sales Market Share by Country (2019-2030)
Figure 22. North America COVID-19 Nasal Swab Test Revenue Market Share by Country (2019-2030)
Figure 23. United States COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe COVID-19 Nasal Swab Test Sales Market Share by Country (2019-2030)
Figure 26. Europe COVID-19 Nasal Swab Test Revenue Market Share by Country (2019-2030)
Figure 27. Germany COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific COVID-19 Nasal Swab Test Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific COVID-19 Nasal Swab Test Revenue Market Share by Region (2019-2030)
Figure 34. China COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America COVID-19 Nasal Swab Test Sales Market Share by Country (2019-2030)
Figure 44. Latin America COVID-19 Nasal Swab Test Revenue Market Share by Country (2019-2030)
Figure 45. Mexico COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa COVID-19 Nasal Swab Test Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa COVID-19 Nasal Swab Test Revenue Market Share by Country (2019-2030)
Figure 50. Turkey COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE COVID-19 Nasal Swab Test Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of COVID-19 Nasal Swab Test by Type (2019-2030)
Figure 54. Global Revenue Market Share of COVID-19 Nasal Swab Test by Type (2019-2030)
Figure 55. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of COVID-19 Nasal Swab Test by Application (2019-2030)
Figure 57. Global Revenue Market Share of COVID-19 Nasal Swab Test by Application (2019-2030)
Figure 58. Global COVID-19 Nasal Swab Test Price (US$/Unit) by Application (2019-2030)
Figure 59. COVID-19 Nasal Swab Test Value Chain
Figure 60. COVID-19 Nasal Swab Test Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
